A series of potent antimicrobial agents have been prepared. These derivatives are cephalosporins carrying a pyridine ring substituted with a heterocycle in the C-3 position. Some of them showed excellent activity not only against Gram-negative organisms including Pseudomonas aeruginosa but also against Gram-positive ones. In view of their biological (1, CTX), cefmenoxime2) (2, CMX), ceftizoxime3) (3, CZX) and ceftriaxone4) (4, CTRX). However their activity against Pseudomonas aeruginosa is relatively weak. On the other hand, cefsulodin5) (5, CFS) and ceftazidime6) (6, CAZ) which are reported to be effective against pseudomonal infections bear a 1-pyridinium group at the C-3 position. These observations prompted the authors to prepare a new series of cephalosporins with 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido and 1-pyridinium groups at the C-7 and C-3 positions, respectively.
[4-(2 or 5-oxazolyl)-l-pyridinium]methyl-3-cephem-4-carboxylate 8f (DQ-2522) and 8g (DQ-2556) were chosen as candidates for further evaluation.
Many cephalosporins with a 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido
substituent at the C-7 position of the cephem nucleus show excellent antimicrobial activity, such as cefotaximei:>
(1, CTX), cefmenoxime2) (2, CMX), ceftizoxime3) (3, CZX) and ceftriaxone4) (4, CTRX) . However their activity against Pseudomonas aeruginosa is relatively weak. On the other hand, cefsulodin5) (5, CFS) and ceftazidime6) (6, CAZ) which are reported to be effective against pseudomonal infections bear a 1-pyridinium group at the C-3 position. These observations prompted the authors to prepare a new series of cephalosporins with 2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido and 1-pyridinium groups at the C-7 and C-3 positions, respectively.
In this report, we describe the synthesis, physico-chemical properties and antimicrobial activities of cephalosporins with 5-membered heterocyclic rings such as imidazole, oxazole and pyrazole etc, in the pyridinium group (8a~8j), as shown in Scheme 1.
Chemistry
Pyridine derivatives each substituted with a 5-membered heterocyclic ring (7a~7j) were prepared according to the literature7~13). The desired compounds (8a~8j) were prepared by reacting the above pyridine derivatives with 7/3-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-acetoxymethyl-3-cephem-4-carboxylic acid or its salt (1) in the presence of Nal. In the reaction of 7b with 1, besides the desired compound (8b), its isomer (9) was obtained.
Sometypical compoundswere crystallized from aqueous sulfuric acid solution to give crystals of their sulfate salts, all of which, except the crystals of 8i, were found to have good stability, as shown inTable2.
Biological Results and Discussion
The minimuminhibitory concentrations (MICs) of the prepared cephalosporins (8a~8j) are given inTable1. JAN. 1987 These cephalosporins are as active against the Gram-negative organisms, i.e., Escherichia coli, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae as CTXand CAZ; against Citrobacter freundii and Serratia marcescens, they are more active than CTXand CAZ;and against Pseudomonas aeruginosa, their activities are 4~8 times greater than that of CTX, and similar to that of CAZ. Moreover, against Gram-positive organisms, these compoundsare more active than CTXand CAZ. Against Staphylococcus aureus and Bacillus subtilis, most of them are 4~8 times more active than CTXand 16~32 times more active than CAZ. However, like CTXand CAZthe compounds are not active against Streptococcus faecalis.
In a comparison of 8g and 8h, the difference of the substitution position of the heterocyclic ring Table 1 . Antimicrobial activities (MIC, iWg/ml) of cephalosporins (8a~8j) and their solubilities in H2O.
8a* 8b 8c**8d* 8e**~8f 8g 8h 8i 8j
r: -ti -ci-a -cr-a-a -a-a-a-a m caz NT: Not tested.
on the pyridine moiety showed no effect on antimicrobial activity. On the other hand, a heterocyclic ring on the pyridine was observed to influence the solubility in water, which is a very important factor in the selection of an injectable candidate. As shown in Table  1 , compounds 8c, 8d, 8e and 8j (with pyrazole, triazole and thiadiazole)
showed low solubility, whilst 8b, 8f, 8g and 8i (with imidazole, oxazole and oxadiazole) had good solubility.
In view of their activity and solubility, four compounds, 8b, 8f, 8g and 8i, were selected, and their LD50s and stabilities were examined ( Table 2) .
Compound8b was more toxic than the other three compounds, and the crystals of the sulfate of 8i were less stable than those of 8f and 8g.
Accordingly, compounds 8f (DQ-2522) and 8g (DQ-2556), which have an oxazole ring on the pyridine, were chosen as candidates for further evaluation. These results have been submitted for publicationelsewhere. IR spectra were obtained using Hitachi Models 260-30 and 270-30. Melting points were determined on a Yanagimoto apparatus and are uncorrected. Quantitative analysis of compounds 8b, 8f, 8g and 8i were performed by reversed-phase HPLC using YMC-Pack A-312 (Yamamura Chemical Laboratory Co., Ltd.) as the stationary phase, H2O -CH3CN-CH3COOH-triethylamine, 400: 60: 2: 1 or 400: 50:4: 1 as the mobile phase, and paminobenzoic acid or sodium benzenesulfonate as an internal standard.
Measurement of In Vitro Antibacterial Activity MICswere measured according to the 2-fold broth dilution method using Mueller-Hinton broth (Difco Laboratories, Detroit, Mich., U.S.A.). The inoculum size was about 105 cfu/ml. The MICwas defined as the lowest concentration which prevented visual growth of bacteria after incubation at 37°C for 18 hours. -3-acetoxymethyl-3 -cephem-4-carboxylate (1 mmol), Nal (10 mmol) and the pyridine derivative (2.5 mmol) were added to a mixture of 0.3 ml of4 n HC1 and 0.9 ml of CH3CNand stirring at 80°C for 1 hour in an atmosphere ofN2.
After being allowed to cool, the reaction mixture was poured into acetone and the precipitate formed was separated by filtration and washed with acetone.
The resulting crude powder was dissolved in water, and the solution was subjected to column chromatography on Diaion HP-20. The column was developed with a mixture of H2O-THF. The eluate was further subjected to reversed-phase HPLCusing Develosil ODS-5 (Nomura Kagaku Co., Ltd.) and developed with a mixture of H2O-CH3CNor a mixture of H2O -CH3CNadjusted to pH 3 with dilute HC1.
The combinedeluate was concentrated in vacuo and the residue was triturated with Et2Oto obtain the title compounds. The physical data of the products are showed in Tables 3 and 4 .
In the case of the reaction of 7b and 1, in addition to the desired compound (8b), 7/3-[2-(2-aminothiazol -4 -yl) -2-methoxyiminoacetamido] -3-[3 -(4 -pyridyl) -1 -imidazolinium] methyl -3 -cephem -4-carboxylate (9) was obtained as a by-product after purification by reversed-phase HPLC. Crystallization of Sulfate Salt JAN. 1987 Compound 8b, 8f, 8g or 8i (7 g) was dissolved in 25 ml ofH2O, and 13 ml of2 n H2SO4 was added thereto. The mixture was allowed to stand for about 30 minutes to give crystals of 7/3-[2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido] -3 -[4-(5-membered ring)-l -pyridinium]methyl-3 -cephem-4-carboxylate sulfate (4 g). The physical data and stabilities of the resulting substances are shown in Table 5 .
